New salts

Details for Australian Patent Application No. 2003232871 (hide)

Owner AstraZeneca AB

Inventors Ahlqvist, Matti; Inghardt, Tord; Sigfridsson, Carl-Gustaf; Bohlin, Martin; Lundblad, Anita

Agent Davies Collison Cave

Pub. Number AU-B-2003232871

PCT Number PCT/SE03/00859

PCT Pub. Number WO2003/101957

Priority 0201661-6 31.05.02 SE

Filing date 27 May 2003

Wipo publication date 19 December 2003

Acceptance publication date 19 August 2010

International Classifications

C07D 205/04 (2006.01) Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom

A61K 31/396 (2006.01) - having three-membered rings, e.g. aziridine

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 0201661-6 31.05.02 SE

12 February 2004 Application Open to Public Inspection

  Published as AU-B-2003232871

19 August 2010 Application Accepted

  Published as AU-B-2003232871

16 December 2010 Standard Patent Sealed

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003232872-METHOD FOR DETERMINING IMMUNE SYSTEM AFFECTING COMPOUNDS

2003232870-Modified release pharmaceutical formulation